English Edward C
SEC-identified person · CIK 1302600 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Xilio Therapeutics, Inc. XLO | Principal Accounting Officer | filed 2022 - 2023 |
| Tesaro, Inc. TSRO | Vice President & Controller | filed 2012 - 2017 |
| Amag Pharmaceuticals, INC. AVM | VP, Controller, Interim CFO | filed 2011 - 2011 |
| Praecis Pharmaceuticals INC PRCS | VP, CFO, Treasurer & Ass. Sec. | filed 2007 - 2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.